Q2 2025 13F Holders as of 30 Jun 2025
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
80,841,255
-
Number of holders
-
1,224
-
Total 13F shares, excl. options
-
74,492,454
-
Shares change
-
+1,002,413
-
Total reported value, excl. options
-
$39,944,909,126
-
Value change
-
+$622,390,857
-
Put/Call ratio
-
127%
-
Number of buys
-
603
-
Number of sells
-
-509
-
Price
-
$536.34
Significant Holders of IDEXX LABORATORIES INC /DE - Common Stock (IDXX) as of Q2 2025
1,354 filings reported holding IDXX - IDEXX LABORATORIES INC /DE - Common Stock as of Q2 2025.
IDEXX LABORATORIES INC /DE - Common Stock (IDXX) has 1,224 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 74,492,454 shares
of 80,841,255 outstanding shares and own 92% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (9,875,985 shares), BlackRock, Inc. (8,373,982 shares), STATE STREET CORP (3,554,424 shares), Fundsmith LLP (2,639,289 shares), GEODE CAPITAL MANAGEMENT, LLC (2,464,290 shares), BAMCO INC /NY/ (2,032,620 shares), MORGAN STANLEY (1,663,326 shares), Bank of New York Mellon Corp (1,451,390 shares), POLEN CAPITAL MANAGEMENT LLC (1,195,425 shares), and Invesco Ltd. (1,158,481 shares).
This table shows the top 1,224 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.